Format

Send to

Choose Destination
Organogenesis. 2010 Jul-Sep;6(3):151-7.

Strategies for organ level tissue engineering.

Author information

1
Stanford University, Hagey Laboratory for Pediatric Regenerative Medicine, Stanford, CA, USA.

Abstract

The field of tissue engineering has made considerable strides since it was first described in the late 1980s. The advent and subsequent boom in stem cell biology, emergence of novel technologies for biomaterial development and further understanding of developmental biology have contributed to this accelerated progress. However, continued efforts to translate tissue-engineering strategies into clinical therapies have been hampered by the problems associated with scaling up laboratory methods to produce large, complex tissues. The significant challenges faced by tissue engineers include the production of an intact vasculature within a tissue-engineered construct and recapitulation of the size and complexity of a whole organ. Here we review the basic components necessary for bioengineering organs-biomaterials, cells and bioactive molecules-and discuss various approaches for augmenting these principles to achieve organ level tissue engineering. Ultimately, the successful translation of tissue-engineered constructs into everyday clinical practice will depend upon the ability of the tissue engineer to "scale up" every aspect of the research and development process.

KEYWORDS:

adipose-derived stromal cells; biomaterials; growth factors; regenerative medicine; scale up; stem cells; tissue engineering

PMID:
21197216
PMCID:
PMC2946046
DOI:
10.4161/org.6.3.12139
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center